Page last updated: 2024-10-27

fentanyl and Cancer of Nasopharynx

fentanyl has been researched along with Cancer of Nasopharynx in 4 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Research Excerpts

ExcerptRelevanceReference
"This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)."7.80Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014)
"This study evaluated the efficacy, safety, and quality of life (QoL) measure of transdermal fentanyl (TDF) for moderate-to-severe pain due to oral mucositis caused by chemoradiotherapy in patients with advanced nasopharyngeal carcinoma (NPC)."3.80Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life. ( Feng, HX; Guo, SP; He, ZY; Li, FY; Sun, JY; Wu, SG; Wu, YJ; Zhou, J, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, SP1
Wu, SG1
Zhou, J1
Feng, HX1
Li, FY1
Wu, YJ1
Sun, JY1
He, ZY1
Granata, R1
Bossi, P1
Bertulli, R1
Saita, L1
Ezri, T1
Roth, Y1
Geva, D1
Konichezky, S1
Marshak, G1
Halperin, D1
Celiker, V1
Basgul, E1
Karagoz, AH1
Dal, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Controlled-release Oxycodone to Control Chemoradiotherapy-induced Moderate or Severe Oral Mucositis Pain in Nasopharyngeal Carcinoma Patients[NCT03045484]70 participants (Anticipated)Interventional2016-05-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for fentanyl and Cancer of Nasopharynx

ArticleYear
Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
    Drug design, development and therapy, 2014, Volume: 8

    Topics: Administration, Cutaneous; Adult; Carcinoma; Chemoradiotherapy; Female; Fentanyl; Humans; Male; Midd

2014
Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse.
    Pain medicine (Malden, Mass.), 2014, Volume: 15, Issue:5

    Topics: Analgesics, Opioid; Breakthrough Pain; Chemoradiotherapy; Coma; Fentanyl; Gastrointestinal Stromal T

2014
Anesthetic management of juvenile nasopharyngeal angiofibroma resection.
    Journal of cardiothoracic and vascular anesthesia, 2003, Volume: 17, Issue:5

    Topics: Adjuvants, Anesthesia; Adolescent; Adult; Angiofibroma; Blood Coagulation; Blood Pressure; Blood Vol

2003
Anesthesia in a patient with nasopharyngeal angiofibroma and hemophilia A.
    Journal of cardiothoracic and vascular anesthesia, 2004, Volume: 18, Issue:6

    Topics: Adjuvants, Anesthesia; Adolescent; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; An

2004